Johnson Anne Nagengast 4
4 · ATAI Life Sciences N.V. · Filed Mar 19, 2025
Insider Transaction Report
Form 4
Johnson Anne Nagengast
Chief Financial Officer
Transactions
- Exercise/Conversion
Restricted Stock Units
2025-03-14−100,000→ 0 total→ Common Shares (100,000 underlying) - Exercise/Conversion
Common Shares
2025-03-14+100,000→ 173,590 total
Footnotes (1)
- [F1]Each restricted stock unit represents a contingent right to receive one common share of the Issuer upon vesting and settlement. 50% of the restricted stock units vested on March 14, 2024, the first anniversary of the grant date and 50% vested on March 14, 2025, the second anniversary of the grant date.